Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial

DOI Full Paper Access

35

Citations

30

References

2020

Year

Hermine I. Brunner, Nicolino Ruperto, Zbigniew Żuber, Rubén Cuttica, Vladimir Keltsev, Ricardo Machado Xavier, Rubén Burgos‐Vargas, Inmaculada Calvo Penadés, Earl D. Silverman, Graciela Espada,

Arthritis & Rheumatology

Abstract

Patients treated with TCZ for polyarticular-course JIA showed high-level disease control for up to 2 years. The TCZ safety profile was consistent with that previously reported.

References

	Year	Citations

Page 1